Oracle's High-Stakes Gambit: The Fiscal Toll of AI Dominance
The $50 Billion Capital Infusion

Credit Ratings on the Precipice
The quality of this new debt is cause for alarm. Rating agencies assigned a Triple-B minus (BBB-) rating to the senior secured debt, positioning it just one notch above speculative grade, or junk status. This thin margin of safety suggests that the credit market views the company's leverage with extreme caution. With negative cash flow projected for the current fiscal year, the path to deleveraging is non-existent. If the company returns to the market next year as expected, it will likely face junk-bond yields, drastically increasing interest expenses.
The At-the-Market Bleed
To supplement the debt, the company is utilizing an At-The-Market (ATM) equity offering. Unlike a traditional overnight block trade, an ATM offering involves selling shares into the secondary market daily. This strategy creates a persistent "overhang," potentially consuming 10% of daily trading volume for the next ten weeks. This constant selling pressure acts as a ceiling on the stock price, punishing existing shareholders to fund capital expenditures that have yet to yield a profit.
Future Implications for the AI Arms Race
The infrastructure promises made to partners like